MusthInsider

Latest On Assembly Biosciences, Inc (ASMB):

Updated on: March 19, 2021

Date/Time	Type	Description	Signal
2023-05-04 22:29 EST	News	Assembly Biosciences GAAP EPS of -$0.37	N/A
2023-03-22 23:50 EST	News	Assembly Biosciences GAAP EPS of -$1.92 in-line	N/A
2022-12-19 15:05 EST	News	Assembly Biosciences surges 19% on positive data from two trials to treat hepatitis B virus	N/A
2022-11-09 02:35 EST	News	Assembly Biosciences GAAP EPS of -$0.48 beats by $0.06	N/A
2022-10-24 18:54 EST	News	Assembly Biosciences downgraded at Truist on trial failure, lack of catalysts	N/A
2022-10-05 18:32 EST	News	Jason Okazaki to succeed John McHutchison as Assembly Biosciences CEO at year-end	N/A
2022-08-09 18:57 EST	News	Assembly Biosciences GAAP EPS of -$0.51	N/A
2022-07-20 18:51 EST	News	Assembly Biosciences to discontinue development of inhibitor vebicorvir, cut workforce	N/A
2022-05-13 07:30 EST	News	Assembly Biosciences GAAP EPS of -$0.48	N/A
2022-03-11 07:35 EST	News	Assembly Biosciences GAAP EPS of -$3.00 misses by $0.90, revenue of $6.25M beats by $0.09M	N/A
2021-11-05 01:28 EST	News	Assembly Biosciences EPS beats by $0.15	N/A
2021-10-20 02:57 EST	News	Assembly Biosciences and Antios ink clinical collaboration agreement	N/A
2021-09-01 19:23 EST	News	Assembly Bio abandons development of phase 2 hepatitis b candidate; shares down 13%	N/A
2021-08-05 22:21 EST	News	Assembly Biosciences EPS beats by $0.11	N/A
2021-08-04 03:06 EST	News	Assembly Biosciences makes COO and CFO promotions	N/A
2021-07-20 20:00 EST	News	Assembly Biosciences announces resignation of CFO	N/A
2021-07-20 19:49 EST	News	Assembly Bio presents data from HBV core inhibitor programs at EASL 2021	N/A
2021-05-07 03:59 EST	News	Assembly Biosciences EPS beats by $0.10	N/A
2021-03-03 15:07 EST	Analyst Rating	The Analyst Target Price has decreased from $17.6 to $11.6.	Neutral
2021-03-02 07:09 EST	Analyst Rating	The Analyst Target Price has decreased from $17.8 to $17.6.	Neutral
2021-03-01 15:07 EST	Earnings Estimate	An EPS average of -$3.32 is estimated for the 2022 year.	Sell
2021-03-01 15:07 EST	Earnings Estimate	An EPS average of -$0.76 is estimated for the quarter ending on June 30, 2021.	Buy
2021-03-01 15:07 EST	Analyst Rating	The Analyst Target Price has decreased from $18.6 to $17.8.	Neutral
2021-02-28 20:13 EST	News	Assembly Biosciences, Inc. (ASMB) CEO on Hepatitis B Program Update Call Transcript	N/A
2021-02-26 15:24 EST	News	Assembly Bio, Arbutus Bio commence trial of triple combo therapy in hepatitis B	N/A
2021-02-26 15:07 EST	Financials	Company financials have been released.	Neutral
2021-02-25 20:03 EST	News	Assembly Biosciences scraps Phase 3 vebicorvir study plans	N/A
2021-02-25 20:03 EST	News	Assembly Biosciences EPS misses by $0.19, misses on revenue	N/A
2020-12-22 11:09 EST	Analyst Rating	The Analyst Target Price has decreased from $19.2 to $18.6.	Neutral
2020-12-13 03:14 EST	Financials	Company financials have been released.	Neutral
2020-12-08 20:20 EST	News	Assembly Biosciences pulls the plug on microbiome program	N/A
2020-12-07 11:09 EST	Analyst Rating	The Analyst Target Price has decreased from $22.6 to $19.2.	Neutral
2020-11-17 02:37 EST	News	Assembly Bio inks deal with Door Pharmaceuticals to develop HBV core protein modulators	N/A
2020-11-15 11:16 EST	Financials	Company financials have been released.	Neutral
2020-11-09 03:14 EST	Financials	Company financials have been released.	Neutral
2020-11-08 23:09 EST	Analyst Rating	The Analyst Target Price has decreased from $45.4 to $22.6.	Neutral
2020-11-07 03:32 EST	News	Assembly Bio plunges on disappointing vebicorvir data in HBV infection study	N/A
2020-11-06 11:10 EST	Earnings Estimate	An EPS average of -$0.67 is estimated for the quarter ending on March 31, 2021.	Sell
2020-11-06 02:49 EST	News	Assembly Biosciences EPS beats by $0.69, beats on revenue	N/A
2020-11-01 17:07 EST	Financials	Company financials have been released.	Neutral
2020-10-30 12:13 EST	Analyst Rating	The Analyst Target Price has increased from $43 to $45.4.	Buy
2020-09-26 04:19 EST	Financials	Company financials have been released.	Neutral
2020-09-10 18:35 EST	News	Assembly Biosciences (ASMB) Investor Presentation - Slideshow	N/A
2020-08-28 19:29 EST	News	Assembly Bio HBV core inhibitors show positive action in studies	N/A
2020-08-28 19:29 EST	News	Assembly Bio files for $300M mixed shelf	N/A
2020-08-27 12:49 EST	News	Assembly Biosciences teams up with Arbutus Biopharma in chronic HBV infection	N/A
2020-08-15 17:17 EST	News	Stocks To Watch: Walmart, Target, Kandi And Gold vs. Bitcoin	N/A
2020-08-10 16:47 EST	Insider Trade	John G McHutchison has directly disposed of 756 shares and currently holds 137,849 shares.	Sell
2020-08-10 16:47 EST	Insider Trade	John G McHutchison has directly disposed of 11,395 shares and currently holds 138,605 shares.	Sell
2020-08-07 00:11 EST	Financials	Company financials have been released.	Neutral

About Assembly Biosciences, Inc (ASMB):

Assembly Biosciences, Inc. operates as a clinical-stage biotechnology company in the United States. The company develops oral therapeutic candidates for the treatment of hepatitis B virus (HBV) infection. Its product candidates include Vebicorvir to treat patients with chronic HBV infection; ABI-H2158, which is in Phase II clinical study for chronic HBV infection; ABI-H3733 that has completed Phase Ia clinical study for the treatment of HBV. The company has collaboration agreements with Allergan Pharmaceuticals International Limited; BeiGene, Ltd.; and Arbutus Biopharma Corporation, as well as strategic license agreements with Indiana University Research and Technology Corporation; and Door Pharmaceuticals, LLC. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in South San Francisco, California.

See Advanced Chart

General

Name Assembly Biosciences, Inc
Symbol ASMB
Type Common Stock
Exchange NASDAQ
Currency USD
Country USA
SectorHealthcare
IndustryBiotechnology
Full Time Employees 139
Last Split Factor1:5
Last Split Date2014-07-14
Fiscal Year EndDecember
IPO Date2010-12-17
Gic SectorHealth Care
Gic GroupPharmaceuticals, Biotechnology & Life Sciences
Gic IndustryBiotechnology
Gic SubIndustryPharmaceuticals
Web URLhttp://www.assemblybio.com

Valuation

Price/Sales (Trailing 12 Mt.) 2.17
Price/Book (Most Recent Quarter) 0.77
Enterprise Value Revenue 5.85
Enterprise Value EBITDA 0.33

Financials

Most Recent Quarter 2020-12-31
Current Year EPS Estimate -$3.15
Next Year EPS Estimate -$2.88
Next Quarter EPS Estimate -$0.76
Profit Margin -79%
Operating Margin -77%
Return on Assets -12%
Return on Equity -24%
Revenue 79.11 million
Earnings Per Share -$3.66
Revenue Per Share $2.23
Gross Profit -22232000
Quarterly Earnings Growth -78.2%

Highlights

Market Capitalization 185.11 million
EBITDA -99942000
Analyst Target Price $11.6
Book Value Per Share $7.07

Share Statistics

Shares Outstanding 38.25 million
Shares Float 33.7 million
% Held by Insiders 465%
% Held by Institutions 94.26%
Shares Short 3.87 million
Shares Short Prior Month 2.49 million
Short Ratio 2.28
Short % of Float 10%
Short % of Shares Outstanding 10%

Technicals

Beta 0.42
52 Week High $27.84
52 Week Low $4.31
50 Day Moving Average 5.55
200 Day Moving Average 9.54

Dividends

Dividend Date N/A
ExDividend Date N/A
Dividend Yield 0%

Assembly Biosciences, Inc (ASMB) Dividend Calendar:

Ex-Dividend Date	Payment Date	Record Date	Declared Date	Amount

Assembly Biosciences, Inc (ASMB) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.

Quarter Date	Report Date	Actual Revenue	Reported EPS	EPS Estimate	Deviation from Estimate
2020-12-31	2021-02-25	$N/A	-$1.11	-$0.90	-22.79%
2020-09-30	2020-11-05	$N/A	-$0.09	-$0.78	88.46%
2020-06-30	2020-08-05	$N/A	$0.19	$0.22	-14.91%
2020-03-31	2020-05-08	$N/A	-$0.76	-$0.98	22.45%
2019-12-31	2020-03-04	$4.77 million	-$0.99	-$1.01	1.74%
2019-09-30	2019-11-07	$4.23 million	-$0.96	-$0.93	-3.23%
2019-06-30	2019-08-05	$3.08 million	-$0.72	-$1.15	37.3%
2019-03-31	2019-05-09	$3.89 million	-$1.05	-$1.06	1.32%
2018-12-31	2019-02-28	$3.74 million	-$1.03	-$0.91	-13.81%
2018-09-30	2018-11-08	$4.29 million	-$0.87	-$1.02	14.29%
2018-06-30	2018-08-08	$3.22 million	-$1.30	-$0.88	-47.73%
2018-03-31	2018-05-07	$3.57 million	-$0.80	-$0.76	-5.72%
2017-12-31	2018-03-08	$3.32 million	-$0.11	-$0.81	86.36%
2017-09-30	2017-11-01	$2.66 million	-$0.71	-$0.88	19.32%
2017-06-30	2017-08-09	$2.36 million	-$0.78	-$0.79	1.27%
2017-03-31	2017-05-08	$684000	-$0.81	-$0.03	-2600%
2016-12-31	2017-03-02	$N/A	-$0.67	-$0.67	0%
2016-09-30	2016-11-09	$N/A	-$0.67	-$0.67	0%
2016-06-30	2016-08-09	$N/A	-$0.59
2016-03-31	2016-05-11	$N/A	-$0.64
2015-12-31	2016-03-11	$N/A	-$0.45
2015-09-30	2015-11-09	$N/A	-$0.38
2015-06-30	2015-08-13	$N/A	-$0.41
2015-03-31	2015-05-08	$N/A	-$0.64
2014-12-31	2015-03-12	$N/A	-$0.38	-$0.57	33.33%
2014-09-30	2014-11-17	$N/A	-$1.33	-$0.48	-177.08%
2014-06-30	2014-08-14	$N/A	-$0.52	-$0.65	20%
2014-03-31	2014-04-02	$N/A	-$1.45	-$1.40	-3.57%
2013-09-30	2013-11-12	$N/A	-$1.25	-$1.30	3.85%
2013-06-30	2013-08-09	$N/A	-$1.20	-$1.00	-20%
2013-03-31	2013-05-10	$N/A	-$1.10	-$1.10	0%
2012-12-31	2013-03-18	$N/A	-$1.40	-$1.54	9.09%
2012-09-30	2012-11-13	$N/A	-$2.05	-$1.94	-5.67%
2012-06-30	2012-08-09	$N/A	-$2.95	-$2.89	-2.08%
2012-03-31	2012-05-07	$N/A	-$3.30	-$2.51	-31.47%
2011-12-31	2012-03-14	$N/A	-$8.90	-$5.42	-64.21%
2011-09-30	2011-11-14	$N/A	-$2.50	-$2.50	0%
2011-06-30	2011-08-15	$N/A	-$4.85	-$2.55	-90.2%
2011-03-31	2011-05-16	$N/A	-$1.90	-$0.87	-118.39%
2010-12-31	2011-03-02	$N/A	-$118.00

Assembly Biosciences, Inc (ASMB) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:

Date	Dec 31 2020	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019
Research Development	33.51 million	N/A	N/A	N/A	N/A
Income Before Tax	-39.42 million	N/A	N/A	N/A	-27.83 million
Selling General Administrative	7.17 million	N/A	N/A	N/A	9.13 million
Gross Profit	N/A	N/A	N/A	N/A	-17.85 million
Ebit	-39.42 million	N/A	N/A	N/A	-26.98 million
Operating Income	-39.64 million	N/A	N/A	N/A	-26.98 million
Income Tax Expense	N/A	N/A	N/A	N/A	-741000
Total Revenue	N/A	N/A	N/A	N/A	4.77 million
Cost of Revenue	N/A	N/A	N/A	N/A	22.62 million
Total Other Income Expense Net	N/A	N/A	N/A	N/A	-841000
Net Income From Continuing Operations	-39.42 million	N/A	N/A	N/A	-27.08 million
Net Income Applicable to Common Shares	-39.42 million	-3.35 million	7.27 million	-26.66 million	-27.08 million

Cash Flow:

Date	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019	Sep 30 2019
Investments	N/A	N/A	N/A	-95.01 million	7.82 million
Change to Liabilities	8.35 million	-35.9 million	N/A	-2.35 million	-1.95 million
Total Cash Flow from Investing Activities	-49.89 million	76.55 million	N/A	-95.02 million	7.82 million
Net Borrowings	N/A	N/A	N/A	N/A	N/A
Total Cash Flow from Financial Activities	N/A	N/A	N/A	137.42 million	1.39 million
Change to Operating Activities	-1.45 million	-2.68 million	N/A	2.6 million	2.09 million
Change in Cash	N/A	N/A	N/A	21.87 million	-9.39 million
Total Cash from Operating Activities	10.65 million	-23.12 million	N/A	-20.53 million	-18.6 million
Depreciation	N/A	N/A	N/A	117000	117000
Other Cash Flow from Investing Activities	N/A	N/A	N/A	N/A	N/A
Change to Inventory	N/A	N/A	N/A	N/A	N/A
Change to Account Receivables	N/A	N/A	N/A	-430000	-41000
Other Cash Flow from Financing Activities	N/A	N/A	N/A	N/A	N/A
Change to Net Income	9.52 million	9.53 million	N/A	6.62 million	6.19 million
Capital Expenditures	N/A	N/A	N/A	15000	N/A

Balance Sheet:

Date	Dec 31 2020	Sep 30 2020	Jun 30 2020	Mar 31 2020	Dec 31 2019
Total Liabailities	42.68 million	N/A	N/A	N/A	66.69 million
Total Stockholder Equity	240.58 million	N/A	N/A	N/A	273.22 million
Other Current Liabilities	3.4 million	N/A	N/A	N/A	8.51 million
Total Assets	283.25 million	N/A	N/A	N/A	339.91 million
Common Stock	34000	33000	33000	32000	32000
Other Current Assets	6.85 million	N/A	N/A	N/A	N/A
Retained Earnings	-501.57 million	-462.16 million	-458.81 million	-466.08 million	-439.42 million
Other Liabilities	N/A	11.52 million	2.53 million	31.86 million	33.17 million
Other Assets	N/A	5.98 million	5.23 million	1.66 million	1.68 million
Cash	59.44 million	N/A	N/A	N/A	46.73 million
Total Current Liabilities	24.43 million	16.8 million	N/A	N/A	24.44 million
Other Stockholder Equity	-270000	-158000	104000	-86000	-201000
Property, Plant & Equipment	1.6 million	12.3 million	12.84 million	13.26 million	13.81 million
Total Current Assets	224.49 million	246.39 million	N/A	N/A	282.78 million
Long Term Investments	N/A	N/A	N/A	N/A	N/A
Net Tangible Assets	198.94 million	228.91 million	225.48 million	210.13 million	231.58 million
Short Term Investments	156.97 million	N/A	N/A	N/A	227.31 million
Long Term Debt	N/A	N/A	N/A	N/A	N/A
Inventory	N/A	N/A	N/A	N/A	N/A
Accounts Payable	21.03 million	1.61 million	N/A	N/A	1.73 million

Assembly Biosciences, Inc (ASMB) Chart:

Assembly Biosciences, Inc (ASMB) News:

Below you will find a list of latest news for Assembly Biosciences, Inc (ASMB) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Assembly Biosciences, Inc (ASMB) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date:

Options Type:

Moneyness:

Expiration Date	Strike	Last Price	Type	Volume	Open Interest	Implied Volatility	In The Money	Change	Change Percent

Latest ASMB Trades:

Date	Shares	Price
Jun 13, 2022 7:48 PM EST	22	$1.945
Jun 13, 2022 7:48 PM EST	28	$1.945
Jun 13, 2022 7:49 PM EST	100	$1.945
Jun 13, 2022 7:52 PM EST	100	$1.945
Jun 13, 2022 7:53 PM EST	100	$1.945

Assembly Biosciences, Inc (ASMB) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Form Type:

Date	Form Type	Form Name	Link
2020-06-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020029795/0001564590-20-029795-index.htm
2020-09-02	UPLOAD	SEC-generated letter	https://www.sec.gov/Archives/edgar/data/1426800/000000000020008294/0000000000-20-008294-index.htm
2019-01-31	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000005341719000016/0000053417-19-000016-index.htm
2019-05-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000005341719000084/0000053417-19-000084-index.htm
2020-02-04	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000005341720000029/0000053417-20-000029-index.htm
2019-02-04	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000021545719003199/0000215457-19-003199-index.htm
2020-02-05	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000083423720004662/0000834237-20-004662-index.htm
2019-02-12	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000090221919000147/0000902219-19-000147-index.htm
2020-01-08	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000090221920000041/0000902219-20-000041-index.htm
2019-04-25	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000091957419003032/0000919574-19-003032-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000091957420001436/0000919574-20-001436-index.htm
2019-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000093583619000118/0000935836-19-000118-index.htm
2019-05-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000093583619000288/0000935836-19-000288-index.htm
2019-12-23	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000093583619000669/0000935836-19-000669-index.htm
2019-11-07	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1426800/000095012319010301/0000950123-19-010301-index.htm
2019-11-07	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1426800/000095012319010303/0000950123-19-010303-index.htm
2020-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000108514620000756/0001085146-20-000756-index.htm
2019-01-31	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000113777419000015/0001137774-19-000015-index.htm
2019-04-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000113777419000061/0001137774-19-000061-index.htm
2019-04-10	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000113777419000062/0001137774-19-000062-index.htm
2020-02-03	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000113777420000021/0001137774-20-000021-index.htm
2018-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032466/0001144204-18-032466-index.htm
2018-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032468/0001144204-18-032468-index.htm
2018-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032469/0001144204-18-032469-index.htm
2018-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032470/0001144204-18-032470-index.htm
2018-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032472/0001144204-18-032472-index.htm
2018-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032474/0001144204-18-032474-index.htm
2018-06-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm
2018-06-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420418034900/0001144204-18-034900-index.htm
2018-07-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm
2018-07-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420418037690/0001144204-18-037690-index.htm
2018-07-13	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1426800/000114420418038336/0001144204-18-038336-index.htm
2018-07-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420418038525/0001144204-18-038525-index.htm
2018-07-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm
2018-07-20	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418039137/0001144204-18-039137-index.htm
2018-07-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420418039140/0001144204-18-039140-index.htm
2018-08-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420418042855/0001144204-18-042855-index.htm
2018-08-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1426800/000114420418042893/0001144204-18-042893-index.htm
2018-08-08	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1426800/000114420418042894/0001144204-18-042894-index.htm
2018-09-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm
2018-10-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420418053659/0001144204-18-053659-index.htm
2018-11-08	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420418058117/0001144204-18-058117-index.htm
2018-11-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1426800/000114420418058118/0001144204-18-058118-index.htm
2018-11-26	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418061513/0001144204-18-061513-index.htm
2018-12-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418064668/0001144204-18-064668-index.htm
2018-12-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418064669/0001144204-18-064669-index.htm
2018-12-14	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420418064671/0001144204-18-064671-index.htm
2019-02-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420419011356/0001144204-19-011356-index.htm
2019-02-28	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1426800/000114420419011361/0001144204-19-011361-index.htm
2019-04-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017733/0001144204-19-017733-index.htm
2019-04-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017736/0001144204-19-017736-index.htm
2019-04-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017740/0001144204-19-017740-index.htm
2019-04-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017748/0001144204-19-017748-index.htm
2019-04-02	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017753/0001144204-19-017753-index.htm
2019-04-04	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1426800/000114420419018190/0001144204-19-018190-index.htm
2019-04-04	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1426800/000114420419018198/0001144204-19-018198-index.htm
2019-04-22	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420419020592/0001144204-19-020592-index.htm
2019-05-02	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420419023321/0001144204-19-023321-index.htm
2019-05-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420419024898/0001144204-19-024898-index.htm
2019-05-09	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1426800/000114420419024904/0001144204-19-024904-index.htm
2019-05-09	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419024908/0001144204-19-024908-index.htm
2019-05-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027155/0001144204-19-027155-index.htm
2019-05-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027156/0001144204-19-027156-index.htm
2019-05-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027157/0001144204-19-027157-index.htm
2019-05-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027158/0001144204-19-027158-index.htm
2019-05-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027159/0001144204-19-027159-index.htm
2019-05-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027160/0001144204-19-027160-index.htm
2019-05-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027161/0001144204-19-027161-index.htm
2019-05-17	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027162/0001144204-19-027162-index.htm
2019-05-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420419027502/0001144204-19-027502-index.htm
2019-08-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420419037651/0001144204-19-037651-index.htm
2019-08-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1426800/000114420419037687/0001144204-19-037687-index.htm
2019-08-05	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1426800/000114420419037697/0001144204-19-037697-index.htm
2019-08-08	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419038642/0001144204-19-038642-index.htm
2019-08-08	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000114420419038644/0001144204-19-038644-index.htm
2019-08-09	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000114420419038915/0001144204-19-038915-index.htm
2019-02-13	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000117266119000428/0001172661-19-000428-index.htm
2019-10-07	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000117266119001984/0001172661-19-001984-index.htm
2020-02-14	SC 13G/A	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000117266120000736/0001172661-20-000736-index.htm
2019-11-12	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000119312519290108/0001193125-19-290108-index.htm
2019-12-11	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1426800/000119312519311678/0001193125-19-311678-index.htm
2019-12-13	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1426800/000119312519313984/0001193125-19-313984-index.htm
2019-12-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000119312519315242/0001193125-19-315242-index.htm
2020-08-28	S-3	Registration statement under Securities Act of 1933	https://www.sec.gov/Archives/edgar/data/1426800/000119312520234664/0001193125-20-234664-index.htm
2020-09-03	CORRESP	Correspondence	https://www.sec.gov/Archives/edgar/data/1426800/000119312520238947/0001193125-20-238947-index.htm
2019-10-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119051355/0001209191-19-051355-index.htm
2019-10-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119051359/0001209191-19-051359-index.htm
2019-10-01	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119051378/0001209191-19-051378-index.htm
2019-10-28	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119054272/0001209191-19-054272-index.htm
2019-10-28	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119054274/0001209191-19-054274-index.htm
2019-11-07	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119055720/0001209191-19-055720-index.htm
2019-11-07	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119055724/0001209191-19-055724-index.htm
2019-12-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm
2019-12-16	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919119060715/0001209191-19-060715-index.htm
2020-01-03	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120001149/0001209191-20-001149-index.htm
2020-03-30	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021707/0001209191-20-021707-index.htm
2020-03-30	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021709/0001209191-20-021709-index.htm
2020-03-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021796/0001209191-20-021796-index.htm
2020-03-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021797/0001209191-20-021797-index.htm
2020-03-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm
2020-03-31	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm
2020-05-29	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120032892/0001209191-20-032892-index.htm
2020-05-29	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120032903/0001209191-20-032903-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120036627/0001209191-20-036627-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120036630/0001209191-20-036630-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120036632/0001209191-20-036632-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120036636/0001209191-20-036636-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120036637/0001209191-20-036637-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120036640/0001209191-20-036640-index.htm
2020-06-15	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120036642/0001209191-20-036642-index.htm
2020-08-10	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm
2020-10-21	3	Initial statement of beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120055488/0001209191-20-055488-index.htm
2020-10-21	4	Statement of changes in beneficial ownership of securities	https://www.sec.gov/Archives/edgar/data/1426800/000120919120055491/0001209191-20-055491-index.htm
2019-02-14	SC 13G	Statement of acquisition of beneficial ownership by individuals	https://www.sec.gov/Archives/edgar/data/1426800/000149315219001848/0001493152-19-001848-index.htm
2019-10-28	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459019038136/0001564590-19-038136-index.htm
2019-11-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459019041796/0001564590-19-041796-index.htm
2020-01-03	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020000214/0001564590-20-000214-index.htm
2020-02-11	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020004234/0001564590-20-004234-index.htm
2020-03-04	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020008685/0001564590-20-008685-index.htm
2020-03-04	10-K	Annual report [Section 13 and 15(d), not S-K Item 405]	https://www.sec.gov/Archives/edgar/data/1426800/000156459020008696/0001564590-20-008696-index.htm
2020-04-16	PRE 14A	Other preliminary proxy statements	https://www.sec.gov/Archives/edgar/data/1426800/000156459020017065/0001564590-20-017065-index.htm
2020-04-27	DEF 14A	Other definitive proxy statements	https://www.sec.gov/Archives/edgar/data/1426800/000156459020018818/0001564590-20-018818-index.htm
2020-04-27	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1426800/000156459020018827/0001564590-20-018827-index.htm
2020-05-07	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020022900/0001564590-20-022900-index.htm
2020-05-08	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1426800/000156459020023566/0001564590-20-023566-index.htm
2020-05-19	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material	https://www.sec.gov/Archives/edgar/data/1426800/000156459020026175/0001564590-20-026175-index.htm
2020-06-16	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020029542/0001564590-20-029542-index.htm
2020-06-18	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020029795/0001564590-20-029795-index.htm
2020-07-20	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020032666/0001564590-20-032666-index.htm
2020-08-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020036846/0001564590-20-036846-index.htm
2020-08-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1426800/000156459020036859/0001564590-20-036859-index.htm
2020-08-27	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020041552/0001564590-20-041552-index.htm
2020-08-28	S-8	Securities to be offered to employees in employee benefit plans	https://www.sec.gov/Archives/edgar/data/1426800/000156459020041777/0001564590-20-041777-index.htm
2020-10-21	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020047123/0001564590-20-047123-index.htm
2020-11-05	8-K	Current report	https://www.sec.gov/Archives/edgar/data/1426800/000156459020051400/0001564590-20-051400-index.htm
2020-11-05	10-Q	Quarterly report [Sections 13 or 15(d)]	https://www.sec.gov/Archives/edgar/data/1426800/000156459020051470/0001564590-20-051470-index.htm
2018-07-10	424B5	Prospectus [Rule 424(b)(5)]	https://www.sec.gov/Archives/edgar/data/1426800/000157104918000393/0001571049-18-000393-index.htm
2020-09-04	EFFECT	Notice of Effectiveness	https://www.sec.gov/Archives/edgar/data/1426800/999999999520002378/9999999995-20-002378-index.htm
2020-02-11	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1426800/999999999720000630/9999999997-20-000630-index.htm
2020-02-26	SEC STAFF	SEC Staff Letter: REDACTED EXHIBIT	https://www.sec.gov/Archives/edgar/data/1426800/999999999720001013/9999999997-20-001013-index.htm

Assembly Biosciences, Inc (ASMB) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Assembly Biosciences, Inc (ASMB). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 465%
Institutional Ownership: 9426%

Transaction Date	Insider Name	Insider Title	Type	Shares Number	Shares Price	Total Transaction	Shares Held After Transaction	Link
2018-12-12	GRAHAM K COOPER	Officer	Buy	100,000.00			100,000.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418064668/0001144204-18-064668-index.htm
2019-08-06	John G McHutchison	CEO and President	Buy	100,000.00			100,000.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420419038644/0001144204-19-038644-index.htm
2018-12-12	Jacqueline Sybil Papkoff	Officer	Buy	10,625.00			10,625.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418064671/0001144204-18-064671-index.htm
2018-12-12	Richard James Colonno	Officer	Buy	20,000.00			110,000.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418064669/0001144204-18-064669-index.htm
2019-03-29	GRAHAM K COOPER	Officer	Buy	17,500.00			117,500.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017736/0001144204-19-017736-index.htm
2019-11-06	Luisa M Stamm	Chief Medical Officer	Buy	12,000.00			12,000.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919119055724/0001209191-19-055724-index.htm
2019-03-29	Richard James Colonno	Officer	Buy	16,250.00			126,250.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017740/0001144204-19-017740-index.htm
2019-12-12	Richard James Colonno	EVP & CSO, Virology Ops	Sell	33,061.00	25.00	826,577.90	127,821.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm
2020-03-31	Richard James Colonno	EVP & CSO, Virology Ops	Sell	7,812.00	15.04	117,523.73	137,009.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm
2020-08-07	John G McHutchison	CEO and President	Sell	756.00	22.50	17,009.62	137,849.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm
2020-08-07	John G McHutchison	CEO and President	Sell	11,395.00	21.76	247,907.34	138,605.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120045952/0001209191-20-045952-index.htm
2020-03-27	Richard James Colonno	EVP & CSO, Virology Ops	Buy	17,000.00			144,821.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021798/0001209191-20-021798-index.htm
2020-03-27	John G McHutchison	CEO and President	Buy	50,000.00			150,000.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021796/0001209191-20-021796-index.htm
2019-12-12	Richard James Colonno	EVP & CSO, Virology Ops	Buy	33,061.00	7.03	232,418.83	160,882.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919119060710/0001209191-19-060710-index.htm
2018-06-01	WILLIAM R RINGO	Director	Sell	1,000.00	42.47	42,470.00	19,465.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm
2018-07-02	WILLIAM R RINGO	Director	Sell	1,000.00	38.50	38,503.00	19,465.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm
2019-10-01	Michael P. Samar	SVP, Finance and Bus. Ops, PAO	Buy	2,500.00			20,327.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919119051378/0001209191-19-051378-index.htm
2018-06-01	WILLIAM R RINGO	Director	Buy	1,000.00	7.20	7,200.00	20,465.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418032476/0001144204-18-032476-index.htm
2018-07-02	WILLIAM R RINGO	Director	Buy	1,000.00	7.20	7,200.00	20,465.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418037217/0001144204-18-037217-index.htm
2019-12-13	Jacqueline Sybil Papkoff	SVP-CSO Microbiome	Sell	1,460.00	21.00	30,661.61	22,915.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919119060715/0001209191-19-060715-index.htm
2019-03-29	Jacqueline Sybil Papkoff	Officer	Buy	13,750.00			24,375.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017753/0001144204-19-017753-index.htm
2020-03-30	Jacqueline Sybil Papkoff	SVP-CSO Microbiome	Sell	1,254.00	14.22	17,830.88	38,661.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm
2020-03-27	Jacqueline Sybil Papkoff	SVP-CSO Microbiome	Buy	17,000.00			39,915.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021800/0001209191-20-021800-index.htm
2020-03-27	Thomas Joseph Russo	CFO	Buy	43,383.00			43,383.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021797/0001209191-20-021797-index.htm
2020-05-27	William E IV Delaney	CSO, Virology	Buy	45,000.00			45,000.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120032903/0001209191-20-032903-index.htm
2020-03-26	Jason A Okazaki	Chief Legal & Business Officer	Buy	50,000.00			52,500.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120021709/0001209191-20-021709-index.htm
2018-09-06	Uri A Lopatin	Chief Med. Off., VP Res. Dev.	Sell	336.00	40.01	13,442.02	613,611.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm
2018-09-05	Uri A Lopatin	Chief Med. Off., VP Res. Dev.	Sell	15,204.00	40.09	609,546.60	613,947.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418048565/0001144204-18-048565-index.htm
2019-03-29	Uri A Lopatin	Chief Medical Officer	Buy	13,750.00			627,361.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017748/0001144204-19-017748-index.htm
2018-07-20	Richard James Colonno	Officer	Buy	25,000.00			65,000.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418039137/0001144204-18-039137-index.htm
2018-07-19	Derek A Small	CEO and President	Buy	1,200.00	41.19	49,428.24	668,091.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm
2018-07-19	Derek A Small	CEO and President	Buy	1,200.00	41.77	50,123.04	669,291.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418039136/0001144204-18-039136-index.htm
2019-03-29	Derek A Small	CEO and President	Buy	32,500.00			701,791.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420419017733/0001144204-19-017733-index.htm
2020-01-02	Derek A Small	Director	Buy	125,000.00			828,791.00	https://www.sec.gov/Archives/edgar/data/1426800/000120919120001149/0001209191-20-001149-index.htm
2018-11-23	Richard James Colonno	Officer	Buy	25,000.00			90,000.00	https://www.sec.gov/Archives/edgar/data/1426800/000114420418061513/0001144204-18-061513-index.htm

Assembly Biosciences, Inc

(NASDAQ:ASMB)